Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,049,967
-$2,765,511 QoQ
Shares Held
380,770
-47.4% QoQ
Ownership
0.383%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 209 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. SPRY ranks #214 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in SPRY

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,049,967 380,770
2026-03-31 $5,815,478 724,219
2025-12-31 $9,460,219 812,036
2025-09-30 $13,323,676 1,325,739
2025-06-30 $25,552,244 1,464,312
2025-03-31 $9,031,848 717,953
2024-12-31 $9,348,534 886,117
2024-09-30 $3,999,897 275,855
2024-06-30 $3,750,688 440,739
2024-03-31 $4,728,957 462,716
2023-12-31 $773,233 141,101
2023-09-30 $905,112 239,448
2023-06-30 $825,125 123,153
2023-03-31 $1,279,240 196,504
2022-12-31 $962,994 112,895
2022-09-30 $526,162 99,652
2022-06-30 $522,732 123,286
2022-03-31 $356,934 101,691
2021-12-31 $521,031 78,233
2021-09-30 $542,402 54,349
2020-12-31 $4,069,254 87,813